首页> 中文期刊> 《检验医学》 >血清半胱氨酸蛋白酶抑制剂C对高血压患者早期肾损伤的诊断性能评价

血清半胱氨酸蛋白酶抑制剂C对高血压患者早期肾损伤的诊断性能评价

         

摘要

Objective To evaluate the clinical significance of serum cystatin C ( Cys C) in early renal impairment in patients with hypertension, and provide the reference for Cys C in the clinical application. Methods 318 patients with primary hypertension and suspected early renal impairment were enrolled. Serum Cys C and the clearance of 99mTcdiethy lenetriaminepentaacetic acid (99mTc-DTPA) were determined. 318 patients were classified into 2 groups according to the clearance of 99m Tc-DTPA (renal impairment group: 127 cases and control group: 191 cases). The receiver operating characteristic (ROC) curve was used to confirm the cut-off value, and the sensitivity, specificity and Youden index were calculated. The accuracy of diagnosing the early renal impairment by serum Cys C was evaluated. The repeatability was assessed simultaneously, and the reliability was analyzed. Results According to the ROC curve, the best cut-off value of diagnosing patients with primary hypertension and early renal impairment was 1.26 mg/L. The sensitivity and specificity were 84. 3% and 79. 1%. The positive and negative predictive values were 72.8% and 88.3% respectively. The positive and negative likelihood ratios were 4.03 and 0.20. The rate of missed diagnosis was 15.7%, and the misdiagnosis rate was 20.9%. The total coincidence and Youden index were 81.1% and 0.63. The area under ROC curve [95% confidence interval (CI) ] was 0.855 (0.814 -0.896). When the daily mean of Cys C was 1.21 and 1.67 mg/L, the within-run coefficient of varication (CV) were 2.9% and 2.7%, and the between-run CV were 3.6% and 3.3%. The daytime CV were 4. 1% and 3.8%, and the total CV were 7.0% and 6.4%.Conclusions Serum Cys C has significant diagnosis value for early renal impairment in primary hypertension patients,and it is suitable for early screening.%目的 评价血清半胱氨酸蛋白酶抑制剂C(Cys C)对高血压患者早期肾损伤的诊断价值,为Cys C在临床的应用提供循证医学证据.方法 对318例原发性高血压并怀疑合并早期肾损伤的患者同时进行血清Cys C和99mTc-二乙三胺五醋酸(99mTc-DTPA)清除率的检测.以99mTc-DTPA清除率为诊断标准将318例患者分为肾损伤组(127例)和对照组(191例).用受试者工作特征(ROC)曲线选取血清Cys C诊断原发性高血压患者早期肾损伤的最佳临界点,计算敏感性、特异性、Youden指数等指标,评价血清Cys C诊断原发性高血压患者早期肾损伤的真实性.同时做血清Cys C检测的重复性试验,评价血清Cys C检测方法的可靠性.结果 根据ROC曲线,Cys C诊断原发性高血压患者早期肾损伤的最佳临界点为1.26 mg/L,其敏感性为84.3%、特异性为79.1%、阳性预测值为72.8%、阴性预测值为88.3%、阳性似然比为4.03、阴性似然比为0.20、漏诊率为15.7%、误诊率为20.9%、总符合率为81.1%、Youden指数为0.63、ROC曲线下面积[95%可信区间(CI)]为0.855(0.814~0.896).当Cys C日平均均值分别为1.21 、1.67 mg/ L 时,该法的批内变异系数(CV)分别为2.9%、2.7%,批间CV分别为3.6%、3.3%,日间CV分别为4.1%、3.8%,总CV分别为7.0%、6.4%.结论 血清Cys C对原发性高血压患者早期肾损伤有较好的诊断价值,尤其适合早期筛查.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号